Alcon to buy rights to eyecare products amid Novartis takeover turmoil
This article was originally published in Scrip
Executive Summary
Alcon is to buy the US rights to two marketed topical eyecare products as well as the ex-Latin America rights to a product in development from the private US firm Sirion Therapeutics.